Authors: Xiao, Z Adam, BL Cazares, LH Clements, MA Davis, JW Schellhammer, PF Dalmasso, EA Wright, GL

Citation: Z. Xiao et al., Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease, CANCER RES, 61(16), 2001, pp. 6029-6033

Authors: Incognito, LS Cazares, LH Schellhammer, PF Kuban, DA Van Dyk, EO Moriarty, RP Wright, GL Somers, KD

Citation: Ls. Incognito et al., Overexpression of p53 in prostate carcinoma is associated with improved overall survival but not predictive of response to radiotherapy, INT J ONCOL, 17(4), 2000, pp. 761-769

Authors: Wright, GL Beckett, ML Newhall, KR Adam, BL Cazares, LH Cartwright, SL Xiao, Z Gong, L Schellhammer, PF

Citation: Gl. Wright et al., Identification of a superimmunoglobulin gene family member overexpressed in benign prostatic hyperplasia, PROSTATE, 42(3), 2000, pp. 230-238

Authors: Wright, GL Cazares, LH Leung, SM Nasim, S Adam, BL Yip, TT Schellhammer, PF Gong, L Vlahou, A

Citation: Gl. Wright et al., Proteinchip((R)) surface enhanced laser desorption/ionization (SELDI) massspectrometry: a novel protein biochip technology for detection of prostatecancer biomarkers in complex protein mixtures, PROSTATE C, 2(5-6), 1999, pp. 264-276

Authors: Beckett, ML Cazares, LH Vlahou, A Schellhammer, PF Wright, GL

Citation: Ml. Beckett et al., Prostate-specific membrane antigen levels in sera from healthy men and patients with benign prostate hyperplasia or prostate cancer, CLIN CANC R, 5(12), 1999, pp. 4034-4040